What are the outcomes of coronary revascularization compared to medical management in people with heart failure and reduced ejection fraction?
Two studies (reported in 14 publications) were included in the review: HEART65 and STICH. The primary outcomes for these studies were all-cause mortality at 30 days, all-cause mortality, quality of life at 12 months, unplanned hospitalization at 12 months, additional revascularization events at 24 months, improvement of NYHA class at 12 months, improvement in ejection fraction at 12 months, and adverse events, such as stroke at 12 months. The evidence from these studies suggests that coronary revascularization may result in improved outcomes compared to medical management in people with heart failure and reduced ejection fraction.